A detailed history of Fifth Third Wealth Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 1,996 shares of RGEN stock, worth $282,952. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,996
Previous 2,165 7.81%
Holding current value
$282,952
Previous $273 Million 8.84%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.79 - $167.35 $20,244 - $28,282
-169 Reduced 7.81%
1,996 $297 Million
Q2 2024

Jul 23, 2024

BUY
$120.0 - $182.95 $259,800 - $396,086
2,165 New
2,165 $273 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Fifth Third Wealth Advisors LLC Portfolio

Follow Fifth Third Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Wealth Advisors LLC with notifications on news.